Other languages ImpediMed Limited

Equities

Delayed Australian S.E. Other stock markets 04:28:36 30/04/2024 BST			5-day change	1st Jan Change
0.083 ^AUD	-6.74%		-7.78%	-42.76%

05:03am	ImpediMed's Qaurterly Revenue Rises in Fiscal Q3; Shares Fall 8%	MT
04-17	Impedimed Implements Organizational Changes; Makes Strategy Chief, COO Redundant	MT

ImpediMed's Qaurterly Revenue Rises in Fiscal Q3; Shares Fall 8%	04:03am
ImpediMed to Present Chronic Breast Cancer-Related Lymphedema Study Results at American Society of Breast Surgeons Annual Meeting	04-11
Impedimed Names Independent Non-Executive Chair	02-27
ImpediMed Narrows Loss in Fiscal H1, Revenue Declines; Shares Fall 7%	02-27
ImpediMed Limited Reports Earnings Results for the Half Year Ended December 31, 2023	02-26
ImpediMed Says New Guidelines for Lymphedema Detection Will Help Company Sales	02-14
ImpediMed CEO, CFO Step Down; Shares Fall 11%	11-20
ImpediMed Limited Announces CEO Changes	11-19
ImpediMed Limited Announces Management Changes	11-19
ImpediMed Secures Payor Clearance for Spectroscopy Device in the US; Shares Rise 4%	11-03
ImpediMed Limited Announces Resignation of Mrs. Janet West AM as Non-Executive Director	03/10/23
Impedimed Limited Announces Board Changes	28/09/23
ImpediMed Appoints Medical Chief; Shares Down 3%	27/09/23
ImpediMed Limited Announce the Appointment of Steven Chen as Chief Medical Officer	26/09/23
Impedimed Widens Fiscal 2023 Loss; Shares Down 3%	31/08/23
ImpediMed Limited Reports Earnings Results for the Full Year Ended June 30, 2023	30/08/23
ImpediMed Limited Shareholders Received a Letter from the Board	16/08/23
ImpediMed Limited Receives Notice from Acadia Park Pty Ltd	02/08/23
ImpediMed Limited Receives Notice from Acadia Park Pty Ltd	02/08/23
ImpediMed Limited Receives Notice from Acadia Park Pty Ltd to Remove Directors	30/07/23

No results for this search